Search

Your search keyword '"Hypnotics and Sedatives economics"' showing total 189 results

Search Constraints

Start Over You searched for: Descriptor "Hypnotics and Sedatives economics" Remove constraint Descriptor: "Hypnotics and Sedatives economics"
189 results on '"Hypnotics and Sedatives economics"'

Search Results

1. A Retrospective Observational Study to Understand Medication Utilization and Lines of Treatment in Patients With Insomnia Disorder.

2. Association of dexmedetomidine use with haemodynamics, postoperative recovery, and cost in paediatric anaesthesia: a hospital registry study.

3. Efficacy and cost analysis of intravenous conscious sedation for long oral surgery procedures.

4. Use of Early Ketamine Sedation and Association With Clinical and Cost Outcomes Among Mechanically Ventilated Patients With COVID-19: A Retrospective Cohort Study.

5. Remimazolam (Byfavo) for short-term procedural sedation.

6. Pragmatic sedation strategies to prevent secondary brain injury in low-resource settings.

7. Cost-Effectiveness of Propofol (Diprivan) Versus Inhalational Anesthetics to Maintain General Anesthesia in Noncardiac Surgery in the United States.

8. Economic Evaluation of Sedative Deprescribing in Older Adults by Community Pharmacists.

9. [Standardization of Hypnotic Agents for Prevention of Falls: A Pharmacoeconomic Study].

10. Clinical and economic impact of the use of dexmedetomidine for sedation in the intensive care unit compared to propofol.

11. Effects of pain, sedation and delirium monitoring on clinical and economic outcome: A retrospective study.

12. Medical, Political, and Economic Considerations for the Use of MAC for Endoscopic Sedation: Big Price, Little Justification?

13. Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department.

14. Patient-controlled sedation with propofol for endoscopic procedures-A cost analysis.

15. Financial impact of an analgosedation protocol for mechanically ventilated patients in a cardiovascular intensive care unit.

16. General practitioners' concepts on issuing out-of-pocket prescriptions for hypnotics and sedatives in Germany.

17. Operator-Directed Procedural Sedation in the Congenital Cardiac Catheterization Laboratory.

18. Better Pairing Propofol Volume With Procedural Needs: A Propofol Waste Reduction Quality Improvement Project.

19. Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort.

20. Purchases of prescription drugs before an alcohol-related death: A ten-year follow-up study using linked routine data.

21. Sedative and Analgesic Drugs Online: A Content Analysis of the Supply and Demand Information Available in Thailand.

22. Outcomes of protocolised analgesia and sedation in a neurocritical care unit.

23. Chloral hydrate enteral infusion for sedation in ventilated children: the CHOSEN pilot study.

24. Moderate sedation billing in 2017.

25. Management of Chronic Insomnia Disorder in Adults.

26. Pharmacy-Driven Dexmedetomidine Stewardship and Appropriate Use Guidelines in a Community Hospital Setting.

27. SEDATION IN COLONOSCOPY BY USING THREE DIFFERENT PROPOFOL INFUSION METHODS AND ANALYSIS OF PLASMA CONCENTRATION LEVELS: A PROSPECTIVE COMPARATIVE STUDY.

28. Comparison of Dexmedetomidine Versus Propofol on Hospital Costs and Length of Stay.

29. A Novel Anesthetic Technique for PEVAR.

30. Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial.

31. Complications of Sedation in Critical Illness: An Update.

32. Impact of different sedation protocols and perioperative procedures on patients admitted to the intensive care unit after maxillofacial tumor surgery of the lower jaw: A retrospective study.

33. A behavioral economic analysis of the nonmedical use of prescription drugs among young adults.

34. Cost-effectiveness analysis of clinic-based chloral hydrate sedation versus general anaesthesia for paediatric ophthalmological procedures.

35. Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective.

36. [Trends in the consumption of anxiolytic and hypnotic drugs in a Colombian population].

37. [Sedation as a Part of Monitored Anesthesia Care (MAC) and Its Introduction to Japanese Clinical Practice].

38. Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation.

39. The association of the use of opioid and psychotropic medications with workers' compensation claim costs and lost work time.

40. [Austrian expenditures on psychopharmaceutical drugs between 2006 and 2013].

41. Diazepam or midazolam for orotracheal intubation in the ICU?

42. An audit into the reasons why treatment was not completed as planned under intravenous sedation in an adult oral surgery department, and the cost implications.

43. Challenges in paediatric procedural sedation: political, economic, and clinical aspects.

44. Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: a randomized, open-blinded, prospective study.

45. Cost effectiveness of a benzodiazepine vs a nonbenzodiazepine-based sedation regimen for mechanically ventilated, critically ill adults.

46. Use of and spending on supportive care medications among Medicare beneficiaries with cancer.

47. Dexmedetomidine #280.

48. Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.

49. Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011.

50. Clinical and economic impact of substituting dexmedetomidine for propofol due to a US drug shortage: examination of coronary artery bypass graft patients at an urban medical centre.

Catalog

Books, media, physical & digital resources